1. Kim J, Harper A, McCormack V, et al. (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature medicine, 31: 1154-1162. [DOI:10.1038/s41591-025-03502-3]

2. Husain A, Khan H, Jamale EF, et al. (2025) Recent Advancements in Breast Cancer Therapies and Biomarkers: Mechanisms and Clinical Significance. Current pharmaceutical biotechnology, 26: 2381-2402. [DOI:10.2174/0113892010343901250204054241]

3. Qian D, Li J, Huang M, et al. (2023) Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy. Biomedicine & pharmacotherapy, 162: 114685. [DOI:10.1016/j.biopha.2023.114685]

4. Elliott MJ, Kim J, Dou A, et al. (2025) Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer. ESMO open, 10: 105286. [DOI:10.1016/j.esmoop.2025.105286]

5. Bertozzi S, Londero AP, Diaz Nanez JA, et al. (2025) Breast cancer care for the aging population: a focus on age-related disparities in breast cancer treatment. BMC Cancer, 25: 492. [DOI:10.1186/s12885-025-13893-8]

6. Nardin S, Mora E, Varughese FM, et al. (2020) Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front Oncol, 10: 864. [DOI:10.3389/fonc.2020.00864]

7. Cheung KL (2020) Treatment Strategies and Survival Outcomes in Breast Cancer. Cancers (Basel), 12: 3735. [DOI:10.3390/cancers12030735]

8. Marra A and Curigliano G (2021) Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer with Chemotherapy. Cancer journal (Sudbury, Mass), 27: 41-49. [DOI:10.1097/PPO.0000000000000498]

9. Bou-Dargham MJ, Draughon S, Cantrell, V et al. (2021) Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy. Journal of Cancer, 12: 6949-6963. [DOI:10.7150/jca.64205]

10. Dvir K, Giordano S, Leone JP (2024) Immunotherapy in Breast Cancer. Int J Mol Sci, 25: 147517. [DOI:10.3390/ijms25147517]

11. Poitevin-Chacón MA, Ramos-Prudencio R, Rumoroso-García JA, et al. (2020) Voluntary breath-hold reduces dose to organs at risk in radiotherapy of left-sided breast cancer. Reports of practical oncology and radiotherapy: journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 25: 104-108. [DOI:10.1016/j.rpor.2019.12.016]

12. Chen F, Jen YM, He K, et al. (2020) Heart-sparing effect of postmastectomy radiotherapy for breast cancer patients: A dosimetric study of cardiac substructures. Medical dosimetry: official journal of the American Association of Medical Dosimetrists, 45: 246-251. [DOI:10.1016/j.meddos.2020.01.004]

13. Mathieu D, Bedwani S, Mascolo-Fortin J, et al. (2020) Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer. Cureus, 12: e7247. [DOI:10.7759/cureus.7247]

14. Huh SJ, Park W, Choi DH (2019) Recent trends in intensity-modulated radiation therapy use in Korea. Radiation oncology journal, 37: 249-253. [DOI:10.3857/roj.2019.00577]

15. Chitapanarux I, Tovanabutra N, Chiewchanvit S, et al. (2019) Emulsion of Olive Oil and Calcium Hydroxide for the Prevention of Radiation Dermatitis in Hypofractionation Post-Mastectomy Radiotherapy: A Randomized Controlled Trial. Breast care (Basel, Switzerland), 14: 394-400. [DOI:10.1159/000496062]

16. De Ruysscher D, Faivre-Finn C, Nackaerts K, et al. (2020) Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer. Annals of Oncology, 31: 41-49. [DOI:10.1016/j.annonc.2019.10.003]

17. Chen Y, Fan W, Zhao Y, et al. (2024) Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine. Molecules (Basel, Switzerland), 29: 102374. [DOI:10.3390/molecules29102374]

18. Zheng H, Wang G, Liu M et al. (2023) Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review. Front Oncol, 13: 1168226. [DOI:10.3389/fonc.2023.1168226]

19. Zhang X, Qiu H, Li C, et al. (2021) The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Bioscience Trends, 15: 283-298. [DOI:10.5582/bst.2021.01318]

20. Sohrabi C, Franchi T, Mathew G et al. (2021) PRISMA 2020 statement: What's new and the importance of reporting guidelines. International Journal of Surgery, 88: 105918. [DOI:10.1016/j.ijsu.2021.105918]

21. Canellas J, Ritto FG, Rodolico A, et al. (2023) The international platform of registered systematic review and meta-analysis protocols (INPLASY) at 3 years: an analysis of 4,658 registered protocols on inplasy.com, platform features, and website statistics. Frontiers in Research Metrics and Analytics, 8: 1135853. [DOI:10.3389/frma.2023.1135853]

22. Higgins JP, Altman DG, Gøtzsche PC, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed), 343: d5928. [DOI:10.1136/bmj.d5928]

23. Wan X, Wang W, Liu J, et al. (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology, 14: 135. [DOI:10.1186/1471-2288-14-135]

24. Luo D, Wan X, Liu J, et al. (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Statistical Methods in Medical Research, 27: 1785-1805. [DOI:10.1177/0962280216669183]

25. Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evidence-Based Mental Health, 22: 153-160. [DOI:10.1136/ebmental-2019-300117]

26. Lortie CJ and Filazzola A (2020) A contrast of meta and metafor packages for meta-analyses in R. Ecology and Evolution, 10: 10916-10921. [DOI:10.1002/ece3.6747]

27. Hu L, Liao T, Cai K (2010) Clinical observation of Kang'ai injection combined with radiotherapy in 30 cases of breast cancer bone metastasis. Hebei Journal of Traditional Chinese Medicine, 32: 1544-1545.

28. Zhai A (2025) Analysis of the effect of Kang'ai injection combined with radiotherapy in the treatment of breast cancer bone metastasis. Chinese Journal of Modern Drug Application, 19: 135-138.

29. Qiao L (2019) Clinical observation of modified Liu Junzi Decoction combined with radiotherapy in postoperative breast cancer patients with spleen-stomach deficiency. Master Thesis, Heilongjiang University of Traditional Chinese Medicine.

30. Shen S, Shen W, Li Y, et al. (2022) Application of modified Pinggan Xiaojie Decoction combined with radiotherapy after breast-conserving surgery for early breast cancer. Chinese Journal of Traditional Chinese Medicine Science and Technology, 29: 615-617.

31. Sima Y M, Ai X, Zhu X, et al. (2016) Effect of radiotherapy combined with Compound Kushen injection on immune function and quality of life in postoperative breast cancer patients. Hainan Medical Journal, 27: 2283-2285.

32. Zhou H, Chen X, Wang Z, et al. (2014) Effect of Xihuang capsule on immune function and quality of life in postoperative breast cancer patients undergoing radiotherapy. China Practical Medicine, 9: 10-11.

33. Hai Y (2018) Effect analysis of Xiaoaishunqi Decoction combined with radiotherapy in early breast cancer patients with liver-qi stagnation after breast-conserving surgery. Henan Medical Research, 27: 1407-1409.

34. Tang H (2019) Symptom outcome analysis of Kang'ai injection combined with radiotherapy in breast cancer bone metastasis. Chinese Community Doctors, 35: 112-114.

35. Dong Y, Liu L, Pang J, et al. (2023) Clinical study on the impact and safety of Zhenqi Liu Jun Yi'ai Decoction combined with IMRT in postoperative breast cancer patients. Clinical Research of Traditional Chinese Medicine, 15: 90-94.

36. He L, Edi S, Ma J, et al. (2025) Prevention and treatment of radiation injury by traditional Chinese medicine: A review. Chinese Herbal Medicines, 17: 220-234. [DOI:10.1016/j.chmed.2024.09.005]

37. Zhang X, Chen X, Wang L, et al. (2021) Review of the Efficacy and Mechanisms of Traditional Chinese Medicines as a Therapeutic Option for Ionizing Radiation Induced Damage. Frontiers in Pharmacology, 12: 617559. [DOI:10.3389/fphar.2021.617559]

38. Zhao X, Luo T, Qiu Y, et al. (2024) Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer. Front Oncol, 14: 1388750. [DOI:10.3389/fonc.2024.1388750]

39. Shakeri-Boroujeni A, Mozdarani H, Mahmoudzadeh M, et al. (2016) Potent radioprotective effect of herbal immunomodulator drug (IMOD) on mouse bone marrow erythrocytes as assayed with the micronucleus test. Int J Radiat Res, 14: 221-228. [DOI:10.18869/acadpub.ijrr.14.3.221]

40. Mohammed Amin SS, Mohammed LMA, Faiq AB, et al. (2023) Radioprotective effect of Nigella sativa Oil (NSO) against radiation-induced hepatic toxicity and haematological alteration in irradiated albino mice. Int J Radiat Res, 21: 89-95.

41. Cai Y, Zhong H, Huang Z (2023) Meta-analysis of efficacy of Chinese medicine compound combined with concurrent radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma. American Journal of Translational Research, 15: 4439-4453.

42. Zhang Y and Shi L (2024) Traditional Chinese medicine combined with chemotherapy for breast cancer after operation: A systematic review and meta-analysis. Medicine, 103: e40264. [DOI:10.1097/MD.0000000000040264]

43. Ghanbari B, Neshasteh Riz A, Hormozi Moghaddam Z (2024) The effect of curcumin in combination with radiation therapy and hyperthermia for a glioblastoma spheroid model. Int J Radiat Res, 22: 145-153. [DOI:10.61186/ijrr.22.1.145]

44. Li Y, Li C, Fan J, et al. (2025) The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review. Cancer Manag Res, 17: 23-34. [DOI:10.2147/CMAR.S503071]

45. Wang M, Yang F, Kong J, et al. (2025) Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: A mechanism discussion. Journal of Ethnopharmacology, 338: 118955. [DOI:10.1016/j.jep.2024.118955]

46. Liu Y, Fang C, Luo J, et al. (2024) Traditional Chinese Medicine for Cancer Treatment. The American Journal of Chinese Medicine, 52: 583-604. [DOI:10.1142/S0192415X24500253]

47. Pan L, Wang X, Long F, et al. (2025) Clinical efficacy and safety evaluation of traditional Chinese medicine for nourishing yin and Replenishing qi in combination with PD-1/PD-L1 inhibitors in the treatment of NSCLC patients: a meta-analysis. Toxicology Research, 14: tfaf013. [DOI:10.1093/toxres/tfaf013]

48. Xia F, Sun S, Xia L, et al. (2022) Traditional Chinese medicine suppressed cancer progression by targeting endoplasmic reticulum stress responses: A review. Medicine, 101: e32394. [DOI:10.1097/MD.0000000000032394]